Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Phage display tools for blood typing.

Don L Siegel1

  • 1Division of Transfusion Medicine, Department of Pathology and Laboratory Medicine, University of Pennsylvania School of Medicine, Philadelphia, PA 19104, USA. siegeld@mail.med.upenn.edu

Current Hematology Reports
|October 20, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Kidney Transplantation in Two Highly Sensitized Candidates after CAR T-Cell Therapy.

The New England journal of medicine·2026
Same author

Predictive biomarkers of response to chimeric antigen receptor (CAR) T-cell therapy for pan-haematologic cancer.

Nature biomedical engineering·2026
Same author

Phase 1 study of autologous T cells bearing fully human chimeric antigen receptors targeting mesothelin in mesothelin-expressing cancers.

Molecular therapy : the journal of the American Society of Gene Therapy·2026
Same author

Engineering a Juxtamembrane-Targeting CAR T-Cell Against Mesothelin: A Novel Binder Resilient to Shed Antigen in Ovarian and Pancreatic Cancer.

bioRxiv : the preprint server for biology·2025
Same author

The incompatible match for transfusion medicine fellowships.

Transfusion·2025
Same author

Cytokine-mediated CAR T therapy resistance in AML.

Nature medicine·2024
Same journal

Safety and efficacy of argatroban in patients with heparin-induced thrombocytopenia.

Current hematology reports·2006
Same journal

The treatment of immune thrombocytopenic purpura in children.

Current hematology reports·2006
Same journal

Volume-reduced platelet concentrates.

Current hematology reports·2006
Same journal

Platelet transfusions in infants with necrotizing enterocolitis.

Current hematology reports·2006
Same journal

Methods for counting platelets in severe thrombocytopenia.

Current hematology reports·2006
Same journal

Flow cytometry for the diagnosis of autoimmune thrombocytopenia.

Current hematology reports·2006
See all related articles

Phage display technology offers a novel solution for blood banks, developing affordable and renewable reagents for blood group antigen typing and pretransfusion tests. This approach addresses challenges in accuracy, cost, and automation for critical blood banking procedures.

Area of Science:

  • Biotechnology
  • Hematology
  • Clinical Diagnostics

Background:

  • Current blood bank testing methods are labor-intensive, error-prone, and costly.
  • Shortages of skilled personnel and reagents, alongside automation difficulties, hinder efficient pretransfusion testing.

Purpose of the Study:

  • To review advancements in phage display technology for blood bank applications.
  • To explore the development of cost-effective, renewable reagents for pretransfusion diagnostics.

Main Methods:

  • Review of current literature on phage display applications in serology.
  • Analysis of phage display's potential for creating novel blood group typing reagents.
  • Assessment of suitability for high-throughput and automated systems.

Related Experiment Videos

Main Results:

  • Phage display enables the creation of inexpensive and renewable reagents for blood group antigen typing.
  • These reagents are compatible with high-throughput and automatable assay systems.
  • Potential to overcome limitations of current plasma-derived reagents and manual methods.

Conclusions:

  • Phage display technology presents a promising avenue for revolutionizing blood bank testing.
  • It offers a scalable, cost-effective, and accurate alternative for pretransfusion diagnostics.
  • This technology can enhance the efficiency and reliability of blood transfusion services.